Situation Awareness Performance in Healthy Young Adults Is Associated With a Serotonin Transporter Gene Polymorphism. Issue 5 (October 2018)

• Record Type: Journal Article
• Authors: González-Giraldo, Yeimy; González-Reyes, Rodrigo E.; Mueller, Shane T.; Piper, Brian J.; Adan, Ana; Forero, Diego A.
• Is Part Of: Psychological reports. Volume 121:Issue 5(2018)
• Page Start: 877
• Page End: 891
• Publication Date: 2018-10
• Subjects: Neurogenetics -- candidate genes -- working memory -- situation awareness -- serotonin -- psychiatric genetics; Psychology -- Periodicals; Psychiatry; Psychology; Psychologie -- Périodiques; Psychology; 150.5
• DOI: 10.1177/0033294117740136
• Languages: English
• ISSNs: 0033-2941

Abstract

Background: Situation awareness (SA) is defined in three levels: SA1 is the perception of the elements in a specific context, SA2 is the comprehension of their meaning, and SA3 is the projection of their status. Purpose: To analyze the possible association of a genetic polymorphism in the serotonin transporter ( SLC6A4 ) gene and performance on the Situational Awareness test (SAtest). Methods: SAtest was applied to a sample of 230 healthy Colombian subjects, using the Psychology Experiment Building Language platform and a functional polymorphism in the SLC6A4 gene was genotyped by polymerase chain reaction. Results: In the SA1 level, s/s genotype carriers had worse accuracy, in comparison with s/l and l/l genotypes. At SA2 level, l/l genotype carriers had better accuracy than s/s and s/l individuals and that in the SA3 level, l/l carriers also had better accuracy. These associations were significant after correction for multiple testing. Conclusions: It is possible that l/l carriers have a better ability to perceive and focus their attention on the elements of their environment and to have the capacity to understand and predict what will happen with those elements. This is the first genetic study of SA performance in healthy participants. Additional investigations of other genes could contribute to the understanding of the molecular correlates of SA in healthy subjects and in neuropsychiatric patients.